Key result
Third BNT162b2 dose assessed for myocarditis risk in military personnel reports no specific abstract results.
Why the study?
Is a third BNT162b2 vaccination dose associated with the risk of myocarditis in military personnel in Israel?
Is a third BNT162b2 vaccination dose associated with the risk of myocarditis in military personnel in Israel?
Third BNT162b2 dose myocarditis assessment in military cohort is hypothesis-generating; leaves open need for confirmatory studies.
This study assessed whether a third vaccine dose was associated with the risk of myocarditis among military personnel in Israel.
No takes yet. Share an insight, caveat, or question.
Friedensohn et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: